Search research articles
Contact Us
Filters
Showing results (251-260 of 687) with videos related to
Page
of 69
Sort By:
International Journal of Cardiology
|
February 1, 2022
Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas
João Pedro Ferreira, Amil M Shah, Brian L Claggett, et al.
The Canadian Journal of Cardiology
|
February 3, 2005
Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure
Eric B Stanton, Mark S Hansen, Michael J Sole, et al.
American Heart Journal
|
November 18, 2005
Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure
John S Rumsfeld, Philip G Jones, Mary A Whooley, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 10, 2017
Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure
Zubaid Rafique, Matthew R Weir, Macaulay Onuigbo, et al.
The New England Journal of Medicine
|
April 2, 2003
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Bertram Pitt, Willem Remme, Faiez Zannad, et al.
Journal of the American College of Cardiology
|
April 28, 2012
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study
Karl Swedberg, Faiez Zannad, John J V McMurray, et al.
Circulation. Heart Failure
|
April 30, 2013
Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study
Henry Krum, Harry Shi, Bertram Pitt, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 12, 2017
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure
Lauren B Cooper, Bradley G Hammill, Eric D Peterson, et al.
European Journal of Heart Failure
|
August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial
Daniela Dobre, Patrick Rossignol, Jan Murin, et al.
European Heart Journal
|
June 17, 2022
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Arjun K Pandey, Deepak L Bhatt, Francesco Cosentino, et al.
Page
of 69
Search research articles
Search
Showing results (251-260 of 687) with videos related to
Sort By:
Page
of 69
International Journal of Cardiology
|
February 1, 2022
Cardiac structure and function and quality of life associations in HFpEF: An analysis from TOPCAT-Americas
João Pedro Ferreira, Amil M Shah, Brian L Claggett, et al.
The Canadian Journal of Cardiology
|
February 3, 2005
Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure
Eric B Stanton, Mark S Hansen, Michael J Sole, et al.
American Heart Journal
|
November 18, 2005
Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure
John S Rumsfeld, Philip G Jones, Mary A Whooley, et al.
Journal of Managed Care & Specialty Pharmacy
|
May 10, 2017
Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure
Zubaid Rafique, Matthew R Weir, Macaulay Onuigbo, et al.
The New England Journal of Medicine
|
April 2, 2003
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Bertram Pitt, Willem Remme, Faiez Zannad, et al.
Journal of the American College of Cardiology
|
April 28, 2012
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study
Karl Swedberg, Faiez Zannad, John J V McMurray, et al.
Circulation. Heart Failure
|
April 30, 2013
Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study
Henry Krum, Harry Shi, Bertram Pitt, et al.
Circulation. Cardiovascular Quality and Outcomes
|
January 12, 2017
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure
Lauren B Cooper, Bradley G Hammill, Eric D Peterson, et al.
European Journal of Heart Failure
|
August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial
Daniela Dobre, Patrick Rossignol, Jan Murin, et al.
European Heart Journal
|
June 17, 2022
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Arjun K Pandey, Deepak L Bhatt, Francesco Cosentino, et al.
Page
of 69